Chapter

Optimizing management in end-stage HF

Miriam Johnson, Karen Hogg, James Beattie and Max Watson

in Heart Failure

Published on behalf of Oxford University Press

Published in print May 2012 | ISBN: 9780199299300
Published online July 2012 | e-ISBN: 9780191740787 | DOI: http://dx.doi.org/10.1093/med/9780199299300.003.0042

Series: Oxford Specialist Handbooks

Optimizing management in end-stage HF

More Like This

Show all results sharing these subjects:

  • Palliative Medicine
  • Cardiovascular Medicine

GO

Show Summary Details

Preview

The care of people with heart failure has been transformed over the past 10 -15 years. Guidelines for pharmacological and device management have been developed and service frameworks have improved services and outlook for patients.

In end stage disease, heart failure management is challenging as individuals may not be able to tolerate standard recommended medications. Thus, although the guidelines are helpful, they need to be applied to each patient and reviewed regularly. In addition, as the patient deteriorates, they may find their tablet burden excessive, and rationalising treatment with symptom relief as the focus rather than long term risk reduction is required. This chapter provides a framework within which clinicians can consider the net patient benefit for management in end stage disease.

Chapter.  2467 words. 

Subjects: Palliative Medicine ; Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.